Current News

Intrinsic Therapeutics, Inc. Names Cary P. Hagan as President & CEO
Intrinsic Therapeutics, a medical device company focused on developing therapies to address the spine market’s many unmet needs, today announced that Cary Hagan has been appointed President and Chief Executive Officer.[Read more]

Intrinsic Therapeutics announces first patient enrolled for Randomized Clinical Trial of its Barricaid® Device
Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid® device.[Read more]

Intrinsic Therapeutics announces CE mark for Barricaid anular prosthesis
Intrinsic Therapeutics, Inc. announced today that it has received a CE mark for its Barricaid® anular prosthesis for use [Read more]

Intrinsic Therapeutics, Inc. Announces First Barricaid Prosthesis Implant
Intrinsic Therapeutics, Inc. announced that Dr. Milorad Vilendecic from the University... [Read more]

Intrinsic Therapeutics, Inc. Announces Kevin Sidow as New Board Member
Intrinsic Therapeutics, Inc., a privately held company, announced that Mr. Kevin Sidow has joined their board ... [Read more]

Intrinsic Therapeutics, Inc.
Raises $25 Million in Venture Capital Financing
Intrinsic Therapeutics, Inc., a privately held company, announced today ... [Read more]

Intrinsic Therapeutics, Inc.
Receives $7.2 Million Venture Capital Financing
Intrinsic Therapeutics, Inc. announced today that it has raised $7.2 million ... [Read more]